LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)

Benjamin Solomon, Jin Seok Ahn, Rafał Dziadziuszko, Fabrice Barlési, Makoto Nishio, Daniel Lee, Jin Sun Lee, W-Z. Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian J. Hochmair, Filippo de Marinis, M.R. Migliorino, Igor Bondarenko, Tania Ochi Lohmann, Tao Xu, A. Cardona Gavaldon, Walter Bordogna, Thorsten Ruf, Yi‐Long Wu